| Literature DB >> 32119669 |
Gabriel W Rangel1, Martha A Clark1, Usheer Kanjee1, Jonathan M Goldberg1, Bronwyn MacInnis2, Maria José Menezes3, Marcelo U Ferreira3, Manoj T Duraisingh1,2.
Abstract
Approximately one-third of the global population is at risk of Plasmodium vivax infection, and an estimated 7.51 million cases were reported in 2017. Although, P. vivax research is currently limited by the lack of a robust continuous in vitro culture system for this parasite, recent work optimizing short-term ex vivo culture of P. vivax from cryopreserved isolates has facilitated quantitative assays on synchronous parasites. Pairing this improved culture system with low-input Smart-seq2 RNAseq library preparation, we sought to determine whether transcriptional profiling of P. vivax would provide insight into the differential survival of parasites in different culture media. To this end we probed the transcriptional signature of three different ex vivo P. vivax samples in four different culture media using only 1000 cells for each time point taken during the course of the intraerythrocytic development cycle (IDC). Using this strategy, we achieved similar quality transcriptional data to previously reported P. vivax transcriptomes. We found little effect with varying culture media on parasite transcriptional signatures, identified many novel gametocyte-specific genes from transcriptomes of FACS-isolated gametocytes, and determined invasion ligand expression in schizonts in biological isolates and across the IDC. In total, these data demonstrate the feasibility and utility of P. vivax RNAseq-based transcriptomic studies using minimal biomass input to maximize experimental capacity.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32119669 PMCID: PMC7067476 DOI: 10.1371/journal.pntd.0008104
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Small volume, cryopreserved Plasmodium vivax isolates provide robust RNAseq data via the Smart-seq2 platform.
A) Experimental strategy. Three separate Brazilian P. vivax patient isolates were thawed, enriched, and cultured in four different culture media. Samples were taken at 4, 20, 36, 44 and 72 hours post-thaw for FACS, provided enough biomass remained, and were sorted based on DNA content or DNA high versus DNA-low when applicable. B) The FACS gating scheme used to separate infected RBCs from uninfected RBCs using Vybrant DyeCycle Green stain. C) Quality control analysis of each individual sample. The hashed horizontal lines represent previously established thresholds below which any particular sample would have been excluded. Error bars represent the standard deviation of technical replicates. D) Transcriptome saturation curves for each sequencing plate showing % protein-coding genes covered (TPM > 1) when 10%, 25%, 50%, 75%, 90%, and 100% of generated reads were analyzed.
Fig 2The majority of transcriptional variation is explained by IDC stage and patient isolate.
A scatter plot of the first two principle components with point colors and associated polygons representing different time points of samples analyzed, point shapes representing different media used, and point size representing the different patient isolate sampled. The hashed box highlights overlap between isolate PvMRMS at hour 4 post-thaw and PvJBC at hour 20 post thaw.
Fig 3Sorting iRBCs by DNA content at 72 hours post-thaw enables isolation of gametocyte from schizont transcriptomes.
A) The gating strategy for DNA-high, DNA-mid and DNA-low FACS-sorted populations after gating for parasite positive cells as in . Representative images of parasites from each sorted population shown with black bar representing 10 micrometers. B) Heatmap depicting the expression in log2(TPM+1) averaged across all available biological replicates of known sexual stage and known schizont stage genes across the intraerythrocytic development cycle. C & D) REVIGO tree maps of gene ontology term biological processes for all genes significantly (Benjamini-Hochberg adjusted p-value < 0.05) upregulated by at least log2(fold change) > 2 in the C) gametocyte population or D) the schizont population.
Highest expressed genes with ≥ 16-fold increased expression in gametocytes over schizonts.
| Gene ID | Gene Name or Symbol | Product Description | Avg TPM 72 hr DNA Mid | Avg TPM 72 hr DNA High | log2(FC) | P value |
|---|---|---|---|---|---|---|
| PVP01_0616100 | P25 | ookinete surface protein P25 | 18166 | 110 | 6.6 | 2.93E-08 |
| PVP01_1109400 | N/A | Common Plasmodium Protein, Unknown Function | 2197 | 64 | 4.1 | 2.96E-08 |
| PVP01_1020200 | PSOP12 | secreted ookinete protein, putative | 5325 | 61 | 5.6 | 5.23E-10 |
| PVP01_1341700 | CCp3 | LCCL domain-containing protein, putative | 2183 | 58 | 4.5 | 6.69E-07 |
| PVP01_0932300 | N/A | Common Plasmodium Protein, Unknown Function | 1682 | 55 | 4.3 | 2.22E-05 |
| PVP01_0508600 | N/A | Common Plasmodium Protein, Unknown Function | 3045 | 36 | 5.8 | 6.29E-11 |
| PVP01_1203200 | GK | glycerol kinase, putative | 1092 | 31 | 4.5 | 1.53E-10 |
| PVP01_1467200 | G377 | osmiophilic body protein G377, putative | 2701 | 31 | 5.8 | 2.46E-11 |
| PVP01_0518500 | DMC1 | meiotic recombination protein DMC1, putative | 2808 | 27 | 4.8 | 1.08E-11 |
| PVP01_0526400 | N/A | Common Plasmodium Protein, Unknown Function | 1711 | 24 | 5.4 | 1.06E-08 |
| PVP01_1017500 | MFS1 | major facilitator superfamily domain-containing protein, putative | 1837 | 22 | 5.6 | 5.25E-10 |
| PVP01_0616000 | P28 | ookinete surface protein P28, putative | 3437 | 20 | 6.5 | 2.80E-10 |
| PVP01_1208000 | P47 | 6-cysteine protein | 1642 | 20 | 5.3 | 8.67E-08 |
| PVP01_0510800 | IMC1i | inner membrane complex protein 1i, putative | 1163 | 19 | 5.1 | 1.09E-08 |
| PVP01_1345600 | N/A | Common Plasmodium Protein, Unknown Function | 1903 | 19 | 6.0 | 1.02E-06 |
| PVP01_1433600 | N/A | Common Plasmodium Protein, Unknown Function | 1512 | 17 | 5.6 | 1.17E-07 |
| PVP01_0508500 | N/A | Common Plasmodium Protein, Unknown Function | 1193 | 10 | 6.0 | 1.93E-11 |
| PVP01_0517400 | HMGB2 | high mobility group protein B2, putative | 1037 | 7 | 5.5 | 1.50E-15 |
| PVP01_1255400 | LAP5 | LCCL domain-containing protein, putative | 1437 | 6 | 7.4 | 2.09E-09 |
| PVP01_0702600 | PH | PH domain-containing protein, putative | 1925 | 2 | 7.7 | 8.54E-12 |
TPM = Transcripts per Million as calucalted by RSEM; FC = Fold Change as calculated by EdgeR; P values are adjusted by the Benjamani & Hochberg method
Fig 4Expression of P. vivax invasion ligands.
Expression levels in transcripts per million (TPM) within isolates PvTCF and PvMRMS at 44 hours maturation in IMDM and FACS sorted by the DNA-high gate of A) confirmed and putatively functional invasion ligands, B) reticulocyte, Duffy, and erythrocyte binding protein (RBP, DBP, and EBP) families, C) merozoite surface protein 3 (MSP3) family and D) tryptophan-rich antigen (TRAG) family. Error bars represent the standard deviation between technical replicates.